positions

Exploring the Influential Leadership Legacy of Wilbert T. Lee: A Philippine Congressional Force.

Source Node:
Time Stamp: May 1, 2024 1:08 PM - Modified On: May 1, 2024 - Published By:
Source Cluster:
Republished By Plato

In a world often colored by political machinations and self-serving motivations, Representative Wilbert T. Lee emerges as a luminary of integrity and sincere dedication to the well-being of the Filipino population. His formidable first term in politics is decorated with a multitude of profoundly significant legislative accomplishments, with standout examples being the Philippine Salt Industry Development Act and the New Agrarian Emancipation Act - both indicative of his commitment to catalyzing economic progress and amplifying local communities' agency. Before stepping foot into the realm of politics, Lee was renowned for

Revolutionizing Cricket Viewing: myco Secures digital streaming rights for HBL PSL Season 9 & 10

Source Node:
Time Stamp: February 8, 2024 11:07 AM - Modified On: February 8, 2024 - Published By:
Source Cluster:
Republished By Plato

Dubai UAE Highlights: myco Secures PSL Streaming Rights: myco, a global blockchain-based video streaming platform, has obtained digital streaming rights for the HBL PSL Seasons 9 & 10, aiming to transform digital sports streaming. "Watch & Earn" Model: Viewers can watch HBL PSL matches in HD for free on myco and earn from the advertising revenue generated, thanks to the platform's innovative "Watch & Earn" model, which rewards viewers based on their watch time. Easy Earnings Withdrawal: Through integration with Simpaisa, myco's payment partner, users can conveniently withdraw their earnings

Latest Survey from Sotera Digital Reveals Shocking State of Mobile Phone Security in the Workplace.

Source Node:
Time Stamp: February 5, 2024 8:17 AM - Modified On: February 5, 2024 - Published By:
Source Cluster:
Republished By Plato

February 5, 2024, New York - Sotera Digital Security, a leading US based provider of secure communications solutions, has today released its findings from a survey it conducted among over 1,000 senior personnel of large businesses and multinational corporations across the globe. Sectors covered by the survey participants focused on those that require the need for ultra-secure and private communications - both regionally and worldwide - with clients, colleagues and suppliers; namely legal, pharmaceutical, media and corporate affairs, government, and blockchain / AI tech specialists. The survey results provide key

Blueberry Protocol Launches High-Leverage DeFi Hub Optimized For Liquidity Access and Risk Control

Source Node:
Time Stamp: January 23, 2024 12:25 PM - Modified On: January 23, 2024 - Published By:
Source Cluster:
Republished By Plato

[PANAMA CITY, PANAMA] January 23, 2024 – Blueberry Protocol today announces the launch of its decentralized prime brokerage terminal, delivering industry-leading Loan-to-Value (LTV) ratios of up to 20x for optimized on-chain trading and yield strategies. Blueberry is the first protocol to enable decentralized access to generalized leverage models with leverage on Ethereum and offers an increasing value opportunity with more sophisticated security management and higher leverage than traditional prime brokerage. By merging innovative and transparent risk management instruments with an advanced leverage architecture, Blueberry aims to broaden accessibility, increase efficiency,

NKGen Biotech Advances Alzheimer’s Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

Source Node:
Time Stamp: December 29, 2023 3:07 AM - Modified On: December 29, 2023 - Published By:
Source Cluster:
Republished By Plato

December 29, 2023 - NKGen Biotech, Inc. (Nasdaq: NKGN) is making strides in Alzheimer's disease (AD) treatment with the dosing of the first patient in its Phase 1/2a trial for SNK01, an autologous natural killer (NK) cell therapy. The innovative product, designed for moderate AD, has demonstrated promising results in neuroinflammation and cognitive function during its Phase 1 safety trial. Key Points: SNK01 Efficacy: NKGen's SNK01, a cryopreserved autologous NK cell therapy, showed improvement in neuroinflammation and cognitive function in the Phase 1 dose-escalation safety trial. The therapy boasts enhanced